- view fewer
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
To compare the efficacy of high-dose intravenous methylprednisolone with intramuscular ACTH in the treatment of acute relapse in multiple sclerosis, we undertook a double-blind, randomized, controlled study involving 61 patients. There was a marked improvement in both groups in the course of the study, but no difference between them in either the rate of recovery or the final outcome. High-dose IV methylprednisolone is a safe alternative to ACTH in the management of acute relapse in MS.
|Title:||Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.|
|Keywords:||Acute Disease, Adrenocorticotropic Hormone, Adult, Clinical Trials as Topic, Female, Humans, Injections, Intramuscular, Injections, Intravenous, Male, Methylprednisolone, Multiple Sclerosis, Recurrence|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Brain Sciences
Archive Staff Only